Results 121 to 130 of about 5,768 (191)

Inactivation of Ube3a in P19 embryonic carcinoma cells by RNA interference

open access: yes, 2006
UBE3A, the gene associated with the neurogenetic disorder Angelman syndrome (AS), is imprinted in certain regions of normal brain, where it is expressed from the maternal allele only, while in most other tissues, the gene is biallelically expressed.
Sotirova, Vihra Nikolova
core  

O papel da Ube3A na diferenciação pré-sináptica

open access: yes
The decrease in UBE3A gene expression levels results in Angelman Syndrome, a rare neurodevelopmental disease characterized by cognitive and motor impairments, epilepsy and EEG abnormalities, as well as lack of speech and sleep difficulties.
Bruno, Inês Conceição Denis
core  

Adenosine Receptor Functionality and Desensitization Machinery in a Neuronal Cell Model of Angelman Syndrome. [PDF]

open access: yesJ Dev Biol
Contestabile M   +5 more
europepmc   +1 more source

Crossing the finish line towards a disease-modifying treatment for Angelman syndrome. [PDF]

open access: yesJ Neurodev Disord
Judson MC   +15 more
europepmc   +1 more source

A xenotransplantation model for reactivation of paternal UBE3A using human-specific antisense oligonucleotides. [PDF]

open access: yesSci Rep
Smeenk H   +11 more
europepmc   +1 more source

HPV16 E6 oncoprotein promotes microhomology-mediated viral integration by increasing PolΘ protein expression. [PDF]

open access: yesProc Natl Acad Sci U S A
Zhu G   +5 more
europepmc   +1 more source

UBE3A isoform-selective and non-selective contributions to Angelman syndrome phenotypes. [PDF]

open access: yesMol Psychiatry
Krzeski JC   +8 more
europepmc   +1 more source

Ubenimex synergizes with the PD-L1 blockade in gastric cancer by competitively binding LAP3 with UBE3A. [PDF]

open access: yesCell Death Dis
Zhao C   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy